Home / Fidelity / FIDELITY COVINGTON TRUST / Fidelity Disruptive Medicine ETF
Fidelity Disruptive Medicine ETF
A series of FIDELITY COVINGTON TRUST
- Vote records
- 535year to 30 June 2026
- Against management
- 6.4%34 of 532 marked votes
- Say-on-pay support
- 94.2%for, of for + against + abstain
- Shareholder-proposal support
- not reportedfor, of for + against + abstain
Fidelity Disruptive Medicine ETF is a series of FIDELITY COVINGTON TRUST. For the year to 30 June 2026 its registrant reported 535 vote records for the series; 6.4% of the votes marked for or against management went against management. It voted for 94.2% of say-on-pay items and for 0.0% of proposals from security holders.
Compared with its registrant and family
| year to 30 June 2026 | This series | Its registrant | Fidelity | Median fund registrant |
|---|---|---|---|---|
| Against-management share | 6.4% | 4.4% | 6.0% | 6.2% |
| Say-on-pay support rate | 94.2% | 95.2% | 94.7% | 91.6% |
| Shareholder-proposal support rate | not reported | 15.3% | 27.6% | 27.5% |
Votes by category
foragainstabstain, withhold or otheramber tick: the portion cast against management
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 314 | 287 | 12 | 8.6% | |
| SECTION 14A SAY-ON-PAY VOTES | 59 | 49 | 3 | 5.1% | |
| AUDIT-RELATED | 69 | 69 | 0 | 0.0% | |
| SHAREHOLDER RIGHTS AND DEFENSES | 2 | 2 | 0 | 0.0% | |
| EXTRAORDINARY TRANSACTIONS | 2 | 2 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 24 | 22 | 2 | 8.3% | |
| COMPENSATION | 32 | 31 | 1 | 3.1% | |
| CORPORATE GOVERNANCE | 42 | 35 | 7 | 2.6% | |
| ENVIRONMENT OR CLIMATE | 1 | 1 | 0 | 0.0% | |
| HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE | 1 | 1 | 0 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 1 | 1 | 0 | 0.0% | |
| OTHER SOCIAL ISSUES | 2 | 1 | 1 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|---|
| year to 30 June 2024 | 614 | 6.2% | 94.2% | 31.8% |
| year to 30 June 2025 | 576 | 6.2% | 92.3% | 37.5% |
| year to 30 June 2026 | 535 | 6.4% | 94.2% | not reported |
Questions
How often did Fidelity Disruptive Medicine ETF vote against management?
6.4% of the votes its registrant marked for or against management in the year to 30 June 2026 (34 of 532).
How did Fidelity Disruptive Medicine ETF vote on executive pay?
It voted for 49 of 52 say-on-pay items cast for, against or abstain (94.2%).
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other shareholders voted or what the outcome was.
Where does the data come from?
From the Form N-PX filed by FIDELITY COVINGTON TRUST, which lists the series that cast each vote. The SEC does not verify the contents. Data runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX filed by FIDELITY COVINGTON TRUST (filer no. 945908); votes attributed to series S000079688 by the filer. Not verified by the SEC. Filings read through 23 Sep 2026.